The Rule 10b5-1 Plan: How Executives Unload Stock Without Fear of Insider Trading Accusations
Many of the most valuable companies in the world today began as small start-ups owned by a few visionary entrepreneurs. As those companies become increasingly valuable, so does the stock held by those founders. It is no secret that much of the wealth amassed by the richest people on the planet is tied up in the stock of their companies. When CEOs and other executives sell a large portion of their incredibly valuable stock, how do they avoid accusations of insider trading? The answer: they implement a Rule 10b5-1 plan.
The Bulls vs. The Bears: The Legality of Short Selling “Stonks”
The Bears of Wall Street have always used their paws to swipe down on financially weak companies by further driving down their stock price. However, the Bulls, recently led by retail investors and Wall Street Bet users, have begun thrusting their horns up into the air to lead an attack on bearish institutions by forcing them to buy back the “Stonks” that they shorted. This stock trading phenomenon, backed with the subjective ethical obligation to protect the little guy on Wall Street, is called the “The Short Squeeze.” While the Bears’ strategy of short selling stocks in the financial market faces public criticism, it is entirely legal. Therefore, financial regulators should encourage these millennial Bulls to take precautions in understanding the legality of trading strategies in the free market.
Market Giants Move to Redesign Healthcare
In January 2018, Warren Buffet, Jamie Dimon, and Jeff Bezos announced that Berkshire Hathaway, JP Morgan Chase, and Amazon would partner together to form a non-profit company aimed at improving the United State healthcare system and combating ever-increasing costs. The idea for the project came about from the ongoing discussion between the three CEOs regarding providing healthcare for their, collectively, approximately 840,000 employees. Even though details are scarce, given the importance of the issue and the prominent names attached to this project, the press, the public, and the market have reacted accordingly. In other words, people are scrambling to figure out what this might mean for their companies and our healthcare system as a whole.